Incident disclosureDisclosed 2026-05-11West Pharmaceutical Services IncSEC filing

West Pharmaceutical Services Inc discloses a cybersecurity incident with data taken without authorization (SEC 8-K, May 2026)

On May 7, 2026, West Pharmaceutical Services, Inc. (the “Company”) determined that the Company has experienced a material cybersecurity attack, in which certain data was exfiltrated by an unauthorized party and certain…

What happened

  • On May 7, 2026, West Pharmaceutical Services, Inc. (the “Company”) determined that the Company has experienced a material cybersecurity attack, in which certain data was exfiltrated by an unauthorized party and certain systems were encrypted.Form 8-K Item 1.05, West Pharmaceutical Services Inc, filed 2026-05-11
  • Upon initial detection of an intrusion on May 4, 2026, the Company promptly activated its incident response protocols, including proactively taking systems offline globally for containment purposes, notifying law enforcement, and engaging external cyber-forensic experts.Form 8-K Item 1.05, West Pharmaceutical Services Inc, filed 2026-05-11
  • The Company has taken steps intended to mitigate the risk of dissemination of the exfiltrated data.Form 8-K Item 1.05, West Pharmaceutical Services Inc, filed 2026-05-11
  • The incident and the Company’s proactive response have temporarily disrupted the Company’s business operations globally.Form 8-K Item 1.05, West Pharmaceutical Services Inc, filed 2026-05-11

The failure pattern

Watch the pattern: Insufficient segmentation lets a foothold spread

Related standards

CollectSEA's mapping through this incident's failure pattern; not an official determination by the standards bodies.

Building something similar?

Describe your design and see every precedent that applies, with safeguards you can hand to your coding agent.

Analyze your design